Drug Shortage Report for DILAUDID

Last updated on 2020-03-23 History
Report ID 12597
Drug Identification Number 00627100
Brand name DILAUDID
Common or Proper name Hydromorphone Hydrochloride, 2mg/mL
Company Name PURDUE PHARMA
Market Status CANCELLED POST MARKET
Active Ingredient(s) HYDROMORPHONE HYDROCHLORIDE
Strength(s) 2MG
Dosage form(s) LIQUID
Route of administration INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS
Packaging size 25 x 1 mL ampoules
ATC code N02AA
ATC description OPIOIDS
Reason for shortage Other (Please describe in comments)
Anticipated start date 2017-06-12
Actual start date 2017-06-12
Estimated end date 2017-12-31
Actual end date 2017-12-31
Shortage status Resolved
Updated date 2020-03-23
Company comments Inventory constraints
Health Canada comments
Tier 3 Status No
Contact Address 3381 STEELES AVENUE EAST
TORONTO, ONTARIO
CANADA M2H 3S7
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2017-06-12 English Compare
v2 2017-06-12 French Compare
v3 2017-06-12 English Compare
v4 2017-06-12 French Compare
v5 2017-06-13 English Compare
v6 2017-06-13 English Compare
v7 2017-06-13 French Compare
v8 2020-03-23 English Compare
v9 2020-03-23 French Compare

Showing 1 to 9 of 9